Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Gilead Sciences Inc GILD

Sector: Healthcare | Sub-Sector: Biotechnology

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
Price: $102.40 Volume: 13.5m
Change: +$1.94 % Change: +1.93%
Day High/Low: 102.74/99.56 52 Week High/Low: 116.83/63.50
Last Traded: December 17, 2014 12:19 Transaction Volume: 556
Open: 100.47 Previous Close: 100.46
Bid: 102.31 Ask: 102.43
Bid Size: 100 Ask Size: 100
Market Cap: 154.5b Shares Out: 1.5b
PE Ratio: 18.3 Dividend Yield: N/A

Latest Bullboard Posts

  • S & P RESEARCH TARGET

    0 stars

    S&P Capital IQ Recommendation STRONG BUY H H H H H Price $104.13 (as of Dec 12, 2014 4:00 PM ET) 12-Mo. Target Price $150.00...

    3 stars


  • TSX DOWN BIGTIME .... GILD "UP"

    0 stars

    One of the few " greens " today on the markets ....    especially in Canada with the oil stocks taking a real beating.   Nice to see.    ...

    2 stars


  • Upside

    0 stars

    Appears to be meeting analysts' target going forward.  Efficacy results have been almost perfect.  Even if there are competitors coming...

    2 stars


  • RE:S & P target has not changed Just as a reminder

    0 stars

    Hi Harjay, hope the S &P estimate will be on target.  It is supposed to be a reputable rating agency.  The biotech field related to...

    2 stars


  • Maybe a really good buy now

    0 stars

    Even Ford Equity Research has given it a "Strong Buy" Rating just a few days ago.  I don't know how good this rating agency is, as I only...

    2 stars